ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,020 | -77.5% | 1,000 | -67.2% | 0.00% | – |
| Q2 2023 | $8,989 | +69.1% | 3,047 | +43.3% | 0.00% | – |
| Q1 2023 | $5,316 | -75.4% | 2,126 | -68.8% | 0.00% | – |
| Q4 2022 | $21,581 | +7.9% | 6,808 | +2.6% | 0.00% | – |
| Q3 2022 | $20,000 | +1900.0% | 6,637 | +1835.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 343 | +363.5% | 0.00% | – |
| Q1 2022 | $1,000 | – | 74 | +7300.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $10,327,000 | – | 559,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |